Search Results

• • 11 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Effects of in utero exposure to ethinyl estradiol on tamoxifen resistance and breast cancer recurrence in a preclinical model

  Authors:Leena Hilakivi-Clarke, Anni Warri, Kerrie B. Bouker, Xiyuan Zhang, Katherine L. Cook, Lu Jin, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017297 words Author abstract, Rep...

   Abstract Only

• Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma

  Authors:Sudhanshu Shukla, Joseph R. Evans, Rohit Malik, Felix Y. Feng, Saravana M. Dhanasekaran, Xuhong Cao, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017323 words Author abstract, Rep...

   Abstract Only

• Recommendations for clinical trial development in mantle cell lymphoma

  Authors:Stephen E. Spurgeon, Brian G. Till, Peter Martin, Andre H. Goy, Martin P. Dreyling, Ajay K. Gopal, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017210 words Author abstract, Rep...

   Abstract Only

• Cost and complications of local therapies for early-stage breast cancer

  Authors:Benjamin D. Smith, Jing Jiang, Ya-ChenTina Shih, Sharon H. Giordano, Jinhai Huo, Reshma Jagsi, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017278 words Author abstract, Rep...

   Abstract Only

• regulation of head and neck squamous cancer stem cells by P13K and SOX2

  Authors:Stephen B. Keysar, Phuong N. Le, Bettina Miller, Brian C. Jackson, Justin R. Eagles, Cera Nieto, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017354 words Author abstract, Rep...

   Abstract Only

• Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer

  Authors:Rico D. Bense, Christos Sotiriou, Martine J. Piccart-Gebhart, John B.A.G. Haanen, Marcel A.T.M. van Vugt, Elisabeth G.E. de Vries, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017424 words Author abstract, Rep...

   Abstract Only

• Risk of advanced neoplasia using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool

  Authors:Thomas F. Imperiale, Menggang Yu, Patrick O. Monahan, Timothy E. Stump, Rebeka Tabbey, Elizabeth Glowinski, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017332 words Author abstract, Rep...

   Abstract Only

• Selective activation of anticancer chemotherapy by cancer-associated fibroblasts in the tumor microenvironment

  Authors:Mi-Gyeong Kim, Yuna Shon, Jinyoung Kim, and Yu-Kyoung OhFrom:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017316 words Author abstract, Rep...

   Abstract Only

• Activation of STING-dependent innate immune signaling by S-Phase-Specific DNA damage in breast cancer

  Authors:Eileen E. Parkes, Steven M. Walker, Laura E. Taggart, Nuala McCabe, Laura A. Knight, Richard Wilkinson, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017296 words Author abstract, Rep...

   Abstract Only

• Bilateral oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers

  Authors:Joanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, Christian F. Singer, Pal Moller, Henry T. Lynch, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 2017271 words Author abstract, Rep...

   Abstract Only

• Inactivation of cancer mutations utilizing CRISPR/Cas9

  Authors:Christina Gebler, Tim Lohoff, Maciej Paszkowski-Rogacz, Jovan Mircetic, Debojyoti Chakraborty, Aylin Camgoz, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 1) Peer-Reviewed

  Jan. 13, 201771 words Author abstract, Rep...

   Abstract Only